|
Access the live webcast and webcast archive for Q4 2009 Par Pharmaceutical Companies, Inc. Earnings Conference Call on Wednesday, February 24, 2010 at 8:30 AM ET. Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is engaged in the business of developing, licensing, manufacturing and distributing generic and branded drugs in the United States. The Company operates in two segments: Par Pharmaceutical, its generic products division, and Strativa Pharmaceuticals, its branded products division. On March 31, 2009, the Company acquired Nascobal Nasal Spray from QOL Medical, LLC.
|
